Gaurav Rathi

402 total citations
9 papers, 150 citations indexed

About

Gaurav Rathi is a scholar working on Immunology, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gaurav Rathi has authored 9 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gaurav Rathi's work include Biosimilars and Bioanalytical Methods (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pharmaceutical studies and practices (3 papers). Gaurav Rathi is often cited by papers focused on Biosimilars and Bioanalytical Methods (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pharmaceutical studies and practices (3 papers). Gaurav Rathi collaborates with scholars based in United States, India and United Kingdom. Gaurav Rathi's co-authors include Avinash Sharma, Ruchika Gupta, Praveen Jadhav, Reena Sharma, Rajiv Gupta, Sanjeev Kumar Mendiratta, Vikram Haridas, Rajendrakumar H. Jani, Mathew Thomas and Minggeng Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Arthritis & Rheumatology.

In The Last Decade

Gaurav Rathi

9 papers receiving 146 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaurav Rathi United States 6 98 50 27 27 26 9 150
Lucy M. Han United States 8 52 0.5× 28 0.6× 51 1.9× 18 0.7× 18 0.7× 13 160
A Lanzon Chile 2 186 1.9× 64 1.3× 29 1.1× 78 2.9× 73 2.8× 2 209
Nicole Selenko-Gebauer Austria 6 265 2.7× 22 0.4× 112 4.1× 14 0.5× 12 0.5× 7 358
Chieh-I Chen United States 6 48 0.5× 113 2.3× 29 1.1× 12 0.4× 5 0.2× 9 168
Johanna Elin Gehin Norway 8 101 1.0× 98 2.0× 5 0.2× 7 0.3× 19 0.7× 29 197
Kathrine Lederballe Grøn Denmark 7 72 0.7× 117 2.3× 11 0.4× 12 0.4× 11 0.4× 14 161
Ivan Staykov Austria 5 264 2.7× 104 2.1× 27 1.0× 108 4.0× 106 4.1× 5 295
T. Ziglioli Italy 6 122 1.2× 165 3.3× 12 0.4× 4 0.1× 8 0.3× 7 262
M. Carreiro France 8 32 0.3× 36 0.7× 33 1.2× 4 0.1× 11 0.4× 18 186
Anna Gimigliano Italy 5 23 0.2× 16 0.3× 42 1.6× 85 3.1× 8 0.3× 8 270

Countries citing papers authored by Gaurav Rathi

Since Specialization
Citations

This map shows the geographic impact of Gaurav Rathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaurav Rathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaurav Rathi more than expected).

Fields of papers citing papers by Gaurav Rathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaurav Rathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaurav Rathi. The network helps show where Gaurav Rathi may publish in the future.

Co-authorship network of co-authors of Gaurav Rathi

This figure shows the co-authorship network connecting the top 25 collaborators of Gaurav Rathi. A scholar is included among the top collaborators of Gaurav Rathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaurav Rathi. Gaurav Rathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Merrill, Joan T., Joel M. Guthridge, Miles Smith, et al.. (2023). Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial. Arthritis & Rheumatology. 75(12). 2185–2194. 33 indexed citations
2.
Merrill, Joan T., Fotios Koumpouras, Anca Askanase, et al.. (2019). FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). Annals of the Rheumatic Diseases. 78. 761–762. 10 indexed citations
3.
Kay, Jonathan, Arvind Chopra, S Chandrashekara, et al.. (2015). AB0420 Secondary Efficacy Outcomes from a Phase 3 Study Support Clinical Equivalence Between BOW015 and Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses. Annals of the Rheumatic Diseases. 74. 1034–1034. 5 indexed citations
4.
5.
Pitale, Shailesh, Mathew Thomas, Gaurav Rathi, et al.. (2014). A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis. Indian Journal of Endocrinology and Metabolism. 19(1). 148–148. 11 indexed citations
6.
7.
Sharma, Avinash, et al.. (2010). Evaluation of factors causing delayed graft function in live related donor renal transplantation.. SHILAP Revista de lepidopterología. 21(2). 242–5. 18 indexed citations
8.
Sharma, Avinash, et al.. (2000). Evaluation of socioeconomic factors in noncompliance in renal transplantation. Transplantation Proceedings. 32(7). 1864–1864. 3 indexed citations
9.
Sharma, Avinash, et al.. (2000). Tuberculosis after renal transplantation. Transplantation Proceedings. 32(7). 1959–1959. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucy M. Han Breakdown of academic impact, for papers by A Lanzon Breakdown of academic impact, for papers by Nicole Selenko-Gebauer Breakdown of academic impact, for papers by Chieh-I Chen Breakdown of academic impact, for papers by Johanna Elin Gehin Breakdown of academic impact, for papers by Kathrine Lederballe Grøn Breakdown of academic impact, for papers by Ivan Staykov Breakdown of academic impact, for papers by T. Ziglioli Breakdown of academic impact, for papers by M. Carreiro Breakdown of academic impact, for papers by Anna Gimigliano
Rankless by CCL
2026